Fundraising FoxClal Biotechnology Industries — Full Portfolio
11 tracked investments · listed companies and verified rows first
MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds.
BiotechHealthtechMedical DevicesYavne
Boaz Gur-Lavie(Chief Financial Officer)inSharon Malka(Director)inEty Klinger(Executive Officer, Director)inTzvi Palash(Executive Officer)Assaf Segal(Director)Sharon Kochan(Director)
PartnerAvi Fischer· solo GP
Co-investorsDeep InsightGandyr InvestmentsIsrael Biotech FundNew Era Capital PartnersPoint72 Ventures
BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
BiotechDigital HealthHealthtechMedical DevicesJerusalem, IL
Amnon Peled(CEO/CSO)Simone Cabilly(Chief Scientist)
PartnerAvi Fischer· solo GP
Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsQiming Venture Partners USASlater Technology FundAccess IndustriesAtlas VentureCowen Healthcare InvestmentsNovartis Institute for Biomedical Research+1 more
Colospan develops the CG-100, an internal bypass medical device for colorectal surgery that provides an alternative to stoma pouches.
BiotechHardwareHealthtechMedical DevicesKfar Saba, IL
Boaz Assaf(CEO)in
PartnerAvi Fischer· solo GP
Co-investorsTriventures
Elicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.
BiotechHealthtech
PartnerAvi Fischer· solo GP
Co-investorsEFung Capital
FDNA develops AI-powered diagnosis and care management tools that help parents, clinicians, and researchers identify developmental delays and rare genetic disorders early.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBoston, US
Moti ShnibergProfessor Lior WolfErik Feingold(Co-Founder and CEO)in
PartnerAvi Fischer· solo GP
BiotechCambridge, US
Richard Gaynor, M.D.(Executive Officer)inRobert Ang, M.D.(Executive Officer)Yasir Al-Wakeel(Executive Officer)inEric Lander(Director)Hugh Dowd(Executive Officer, Director)
BoardCary Pfeffer, M.D.(Director)
Co-investorsNextech InvestSofinnova VenturesThird Rock VenturesWellington Management
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.
HardwareHealthtechMedical Devices
Erez Golan(Founder)in
PartnerAvi Fischer· solo GP
Co-investorsAccelmed PartnersIndaco Venture PartnersKreos CapitalSofinnova PartnersInnogest Capital
Sight develops immune signatures by analyzing live immune cells using AI to generate clinical insights.
AI & Machine LearningBiotechDigital Health
Ben Leshem(Chief Technology Officer)Nitsan Maayan-Rabinowich(Chief Executive Officer)Asi Cohen-Dotan(Chief Product & Clinical Officer)
PartnerAvi Fischer· solo GP
Co-investorsEmery CapitalGEOC
Constellation Pharmaceuticals was a Cambridge, MA clinical-stage biopharmaceutical company developing epigenetics-based cancer therapies, including BET and EZH2 inhibitors.
BiotechHealthtech
PartnerAvi Fischer· solo GP
Co-investorsExSight VenturesLongitude CapitalTachyon VenturesThe Column Group
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.